ADVERTISEMENT
site_logo
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
  • Web Stories
  • edex_worksEDEXWORKS
ADVERTISEMENT
COVID-19

Published: 12th May 2021     

Government taking steps to ramp up availability of medicines to treat Black Fungus

Doctors have raised an alarm about Black Fungus which can turn dangerous if left untreated, amid reports of re-emergence of the rare deadly fungal infection among COVID patients

Edex Live
Edex Live
f_icon t_icon i_icon l_icon koo_icon whatsapp_icon email_icon Google News

Share Via Email

Hospital_Beds

Representational image (Source: EPS)

The government has said it is taking steps to ramp up availability of Amphotericin B - to fight Mucormycosis, a Black Fungus infection in COVID patients. The sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post-COVID complication, said the Chemical and Fertilizer Ministry.

Doctors have raised an alarm about Mucormycosis, also known as Black Fungus, which can turn dangerous if left untreated, amid reports of re-emergence of the rare deadly fungal infection among COVID-19 patients across hospitals in Delhi, Pune and Ahmedabad. The fungal infection is caused by a group of molds called Mucormycetes. These molds live throughout the environment. Mucormycosis mainly affects people who have health problems or take medicines that lower the body's ability to fight germs and sickness.

The Government of India is therefore engaging with the manufacturers to ramp up production of the drug. The supply situation is expected to improve with extra imports of this drug and increase in its production domestically. After reviewing the stock position with the manufacturers/importers, and the demand pattern of Amphotericin B the Department of Pharma, has on May 11, 2021, allocated this drug amongst the States/UTs based on expected supply that will be available from May 10 to May 31, 2021, the ministry said.

States have been requested to put in place a mechanism for equitable distribution of supplies amongst Government and Private hospitals and health care agencies. States have also been requested to publicise in the State the 'Point of Contact' for Private and Government hospitals to obtain the drug from this allocation. Further, States have been requested that judicious use may be made of the stock that has been already supplied as well as stock that has been allocated. The arrangements for supply will be monitored by National Pharmaceuticals Pricing Authority (NPPA).

telegram
TAGS
COVID-19

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

newsletter_icon
Mailbox
edexlive@gmail.com
fb_icon
Facebook
twitter_icon
Twitter
insta_icon
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

The New Indian Express | The Morning Standard | Dinamani | Kannada Prabha | Samakalika Malayalam | Cinema Express | Indulgexpress | Events Xpress

Contact Us | About Us | Privacy Policy | Terms of Use | Advertise With Us

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take

Copyright - edexlive.com 2023. All rights reserved. Website Designed, Developed & Maintained by Express Network Private Ltd.